Ci Investments Inc. 10x Genomics, Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 4,833 shares of TXG stock, worth $69,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,833

Previous 4,978 2.91%

Holding current value

$69,160

Previous $97,000 12.37%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.71 - $23.49 $2,277 - $3,406	-145 Reduced 2.91%	4,833 $109,000
Q2 2024 Aug 12, 2024	BUY	$19.45 - $37.37 $48,955 - $94,060	2,517 Added 102.28%	4,978 $97,000
Q1 2024 May 13, 2024	BUY	$36.08 - $54.3 $1,659 - $2,497	46 Added 1.9%	2,461 $92,000
Q4 2023 Feb 12, 2024	BUY	$34.32 - $57.55 $20,797 - $34,875	606 Added 33.5%	2,415 $135,000
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $1,797 - $2,771	-44 Reduced 2.37%	1,809 $75,000
Q2 2023 Aug 11, 2023	SELL	$50.96 - $58.72 $44,131 - $50,851	-866 Reduced 31.85%	1,853 $103,000
Q1 2023 May 12, 2023	SELL	$35.33 - $55.79 $1,236 - $1,952	-35 Reduced 1.27%	2,719 $152,000
Q4 2022 Feb 10, 2023	BUY	$24.4 - $41.3 $58,779 - $99,491	2,409 Added 698.26%	2,754 $100,000
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $4,328 - $7,993	-152 Reduced 30.58%	345 $10,000
Q2 2022 Aug 12, 2022	SELL	$36.95 - $82.41 $3,621 - $8,076	-98 Reduced 16.47%	497 $22,000
Q1 2022 May 12, 2022	BUY	$55.7 - $145.79 $8,410 - $22,014	151 Added 34.01%	595 $45,000
Q4 2021 Feb 11, 2022	BUY	$135.05 - $182.59 $12,964 - $17,528	96 Added 27.59%	444 $66,000
Q3 2021 Nov 12, 2021	BUY	$145.58 - $192.14 $50,661 - $66,864	348 New	348 $51,000

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. 10x Genomics, Inc. Transaction History